WARFARIN SODIUM

Product NDC: 51655-283
11-digit product format: 516550283
Labeler code: 51655
Product ID: 51655-283_837a0699-2324-451c-bd28-9b168fe135e5
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: WARFARIN SODIUM
Dosage form: TABLET
Route: ORAL
Labeler: Northwind Pharmaceuticals, LLC
Application: ANDA040663
Marketing category: ANDA
Marketing start: 2015-03-10
Marketing end: 0000-00-00
Substance: WARFARIN SODIUM
Active strength: 5 mg/1
Pharmacologic classes: Vitamin K Antagonist [EPC],Vitamin K Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	51655-283		D	Discontinued by firm		2026-07-31
excluded package	package	51655-283	51655-283-26	D	Discontinued by firm		2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 9 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A040663-001	WARFARIN SODIUM	WARFARIN SODIUM	1MG	TABLET / ORAL	AB	2006-05-30
A040663-002	WARFARIN SODIUM	WARFARIN SODIUM	2MG	TABLET / ORAL	AB	2006-05-30
A040663-003	WARFARIN SODIUM	WARFARIN SODIUM	2.5MG	TABLET / ORAL	AB	2006-05-30
A040663-004	WARFARIN SODIUM	WARFARIN SODIUM	3MG	TABLET / ORAL	AB	2006-05-30
A040663-005	WARFARIN SODIUM	WARFARIN SODIUM	4MG	TABLET / ORAL	AB	2006-05-30
A040663-006	WARFARIN SODIUM	WARFARIN SODIUM	5MG	TABLET / ORAL	AB	2006-05-30
A040663-007	WARFARIN SODIUM	WARFARIN SODIUM	6MG	TABLET / ORAL	AB	2006-05-30
A040663-008	WARFARIN SODIUM	WARFARIN SODIUM	7.5MG	TABLET / ORAL	AB	2006-05-30
A040663-009	WARFARIN SODIUM	WARFARIN SODIUM	10MG	TABLET / ORAL	AB	2006-05-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 9 matching rows.

Application-product, TE code table
Application-product	TE code
A040663-001	AB
A040663-002	AB
A040663-003	AB
A040663-004	AB
A040663-005	AB
A040663-006	AB
A040663-007	AB
A040663-008	AB
A040663-009	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-01 22:54:32	2026-06	A040663-001	WARFARIN SODIUM	1MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-002	WARFARIN SODIUM	2MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-003	WARFARIN SODIUM	2.5MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-004	WARFARIN SODIUM	3MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-005	WARFARIN SODIUM	4MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-006	WARFARIN SODIUM	5MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-007	WARFARIN SODIUM	6MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-008	WARFARIN SODIUM	7.5MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-009	WARFARIN SODIUM	10MG	TABLET / ORAL	AB	2006-05-30	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-01 22:54:32	2026-06	A040663-001	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-002	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-003	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-004	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-005	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-006	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-007	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-008	AB	1	`a50c72e98297…`
2026-08-01 22:54:32	2026-06	A040663-009	AB	1	`a50c72e98297…`

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51655-283-26	2026-01-02	C162847	48780-1	9d75b9d0-2d46-f424-e053-dadaa90a57ce	WARFARIN SODIUM
51655-283-26	2020-01-31	C162847	48780-1	9d75b9d0-2d46-f424-e053-dadaa90a57ce	WARFARIN SODIUM

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version	Uploaded
WARFARIN SODIUM	ACTIVE INGREDIENT	6153CWM0CL	WARFARIN SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1
WARFARIN	ACTIVE MOIETY	5Q7ZVV76EI	WARFARIN SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51655-283	WARFARIN SODIUM TABLET [NORTHWIND PHARMACEUTICALS, LLC]	1	Legacy NDC	20150324_1e19e5a0-1c0c-4a6d-bd0f-fd591c134639.zip